Citation Impact

Citing Papers

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Clinical importance of acquired cystic disease of the kidney in patients undergoing dialysis.
1983 StandoutNobel
Bone Histomorphometry : Standardization of Nomenclature, Symbols, and Units
1987 Standout
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Can the Nephrologist Prevent Dialysis-Related Amyloidosis?
1991
Identification of the renal erythropoietin-producing cells using transgenic mice
1993 StandoutNobel
Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients
2007
Cholesterol crystal embolism: Diagnosis and treatment
2006
Intranasal Mupirocin to Prevent PostoperativeStaphylococcus aureusInfections
2002 Standout
Mechanisms of Vascular Calcification
2007
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
2006 Standout
In Vitro Resistance to Thrombin‐Induced Platelet Microbicidal Protein in Isolates ofStaphylococcus aureusfrom Endocarditis Patients Correlates with an Intravascular Device Source
2000
Oral Phosphate Binders in Patients with Kidney Failure
2010
Cardiac Disease in Chronic Uremia: Pathophysiology
1997
Neoplasms in Dialysis Patients: A Population-Based Study
1989
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
2008 Standout
Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study
2005
Cancer in patients on dialysis for end-stage renal disease: an international collaborative study
1999 Standout
Cardiovascular Mortality in Haemodialysis Patients Treated with Epoetin Beta – A Retrospective Study
2000
Systematic Review and Meta-analysis of Exercise Tolerance and Physical Functioning in Dialysis Patients Treated With Erythropoiesis-Stimulating Agents
2010
Cinacalcet HCl, an Oral Calcimimetic Agent for the Treatment of Secondary Hyperparathyroidism in Hemodialysis and Peritoneal Dialysis
2005
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
2009 Standout
Sites of erythropoietin production
1997 StandoutNobel
Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis
2000 Standout
Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis
2005
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
2004 Standout
The interstitial response to renal injury: Fibroblast–like cells show phenotypic changes and have reduced potential for erythropoietin gene expression
1997 StandoutNobel
Waves of resistance: Staphylococcus aureus in the antibiotic era
2009 Standout
Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement
1990
Low dose erythropoietin in maintenance haemodialysis: improvement in quality of life and reduction in true cost of haemodialysis
1991
Chronic kidney disease
2011 Standout
Acute Renal Failure
1996 Standout
Polymer conjugates as anticancer nanomedicines
2006 Standout
Anemia management and outcomes from 12 countries in the dialysis outcomes and practice patterns study (DOPPS)
2004
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease
1994 Standout
Soft tissue calcification in pediatric patients with end-stage renal disease
1990
Prospective Assessment of Cholesterol Embolization in Patients With Acute Myocardial Infarction Treated With Thrombolytic vs Conservative Therapy
1995
Cardiorenal Syndrome
2008 Standout
Homocysteine-Lowering Vitamin B Treatment Decreases Cardiovascular Events in Hemodialysis Patients
2006
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients
2007
Thyroid Hormone Analogues for the Treatment of Metabolic Disorders: New Potential for Unmet Clinical Needs?
2012
Production of Erythropoietin by Liver Cells in Vivo and in Vitro
1994 StandoutNobel
Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients
2007
Molecular biology of erythropoietin
1993 StandoutNobel
Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density
2005
Arterial Hypertension Induced by Erythropoietin and Erythropoiesis-Stimulating Agents (ESA)
2009
Allergy to formaldehyde and ethylene-oxide
1991
Recombinant Human Erythropoietin in Anemic Patients with End-Stage Renal Disease
1989
Effects of haemoglobin normalization on quality of life and cardiovascular parameters in end‐stage renal failure
2000
Impact of Hemodialysis on Left and Right Ventricular Doppler Diastolic Filling Indices
1992
Infective endocarditis
2004 Standout
Organ distribution of erythropoietin messenger RNA in normal and uremic rats
1991 StandoutNobel
Chronic Kidney Disease
2016 Standout
Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)
2003
Anemia of Chronic Disease
2005 Standout
Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography
2010 Standout
The dawning era of polymer therapeutics
2003 Standout
Treatment of Staphylococcus aureus Colonization and Prophylaxis for Infection with Topical Intranasal Mupirocin: An Evidence-Based Review
2003
Cognitive function in Stage 5 chronic kidney disease patients on hemodialysis: No adverse effects of lanthanum carbonate compared with standard phosphate-binder therapy
2006
The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin
1989
EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSIS
1986 Standout
Role of dietary factors in the progression of chronic renal disease
1983
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents
2005 Standout
Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee
1987 Standout
A comparative review of the efficacy and safety of established phosphate binders: calcium, sevelamer, and lanthanum carbonate
2007
The Tumor Lysis Syndrome
2011 Standout
Biocompatibility of biomaterials: hemocompatibility, immunocompatiblity and biocompatibility of solid polymeric materials and soluble targetable polymeric carriers
1996
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
A new semiautomatic method for quantitative static and dynamic bone histology
1982
Biocompatibility of hemodialysis membranes.
1990
Expression of a homologously recombined erythopoietin-SV40 T antigen fusion gene in mouse liver: evidence for erythropoietin production by Ito cells
1994 StandoutNobel
Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease
2010
Thyroid Hormone Regulation of Metabolism
2014 Standout
A Critical Appraisal of the Quality of Quality-of-Life Measurements
1994 Standout
Comparison of Survival Probabilities for Dialysis Patients vs Cadaveric Renal Transplant Recipients
1993 Standout
Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks
1997 Standout
Epidemiology of Peripheral Artery Disease
2015 Standout
Erythropoietin: Biology and Clinical Use
1989
Erythropoietin
1991 Standout
SCF/β-TrCP Promotes Glycogen Synthase Kinase 3-Dependent Degradation of the Nrf2 Transcription Factor in a Keap1-Independent Manner
2011 Standout
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Vascular Calcification
2006 Standout
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Peripheral Arterial Disease in Patients With End-Stage Renal Disease
2006
Interleukin-1 and interleukin-1 antagonism
1991 Standout
Vascular Calcification
2008 Standout
Bone histomorphometric reproducibility in normal patients
1981
β-Trcp mediates ubiquitination and degradation of the erythropoietin receptor and controls cell proliferation
2007

Works of J. Bömmer being referenced

Protein Layer Formation on Artificial Membranes
2015
Doppler Echocardiographic Findings in Dialysis Patients
1990
Efficacy Comparison of Intravenous and Subcutaneous Recombinant Human Erythropoietin Administration in Hemodialysis Patients
2015
Beta-2-Microglobulin-Derived Amyloid- Problems and Perspectives
1988
Long-term comparison of a calcium-free phosphate binder and calcium carbonate - phosphorus metabolism and cardiovascular calcification
2004
Ethylene Oxide Sterilization � A Risk for Hemodialysis Patients
2015
Mechanisms of Improved Physical Performance of Chronic Hemodialysis Patients After Erythropoietin Treatment
1990
Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)
2003
Blood Pressure Changes during Treatment with Recombinant Human Erythropoietin
2015
Effects of Hemodialysis on Platelets
2015
Effects of Recombinant Human Erythropoietin Treatment in End-Stage Renal Failure Patients
2015
ANAPHYLACTOID REACTIONS IN DIALYSIS PATIENTS: ROLE OF ETHYLENE-OXIDE
1985
Elimination of Staphylococcus aureus in Hemodialysis Patients
1995
Acute Renal Failure, Hypertension and Skin Necrosis in a Patient with Streptokinase Therapy
1984
[A critical analysis of micromorphometry in metabolic osteopathy (author's transl)].
1974
D-thyroxine reduces lipoprotein(a) serum concentration in dialysis patients.
1998
Vascular calcifications under maintenance hemodialysis
1977
Acquired renal cysts in uremic patients--in vivo demonstration by computed tomography.
1980
Storage of Silicone Particles in Macrophages: An Iatrogenic Complication in Dialysis Patients
1982
Recombinant Human Erythropoietin Therapy in Haemodialysis Patients—Dose Determination and Clinical Experience
1987
What Is the Evidence for Activated Coagulation in Glomerulonephritis ?
1982
Dose-related effects of recombinant human erythropoietin on erythropoiesis. Results of a multicenter trial in patients with end-stage renal disease.
1988
Determinants of Plasma β2 Microglobulin Concentration: Possible Relation to Membrane Biocompatibility
1987
Rankless by CCL
2026